Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study
Authors:
Open Access
- 16 February 2023
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 270 (5) , 2550-2558
Abstract
Introduction: Parkinson’s disease (PD) is a neurodegenerative movement disorder that is typically diagnosed clinically. DaT-SPECT scanning (DaT Scan) can be used when there is diagnostic difficulty differentiating from non-neurodegenerative Parkinsonism. This study assessed the effect of DaT Scan imaging on diagnosis and subsequent clinical management of these disorders. Methods: This single-trust retrospective study involved 455 patients who had undergone DaT scans for investigation for Parkinsonism, between 01/01/2014 and 31/12/2021. Data collected included patient demographics, date of clinical assessment, scan report, pre-scan and post-scan diagnosis, and clinical management. Results: The mean age at scan was 70.5 years and 57% were male. The percentage of patients who had an abnormal scan result was 40% (n = 184), whilst 53% (n = 239) had a normal scan result, and 7% (n = 32) had an equivocal scan. Pre-scan diagnosis was consistent with scan results in 71% of cases of neurodegenerative Parkinsonism, whereas this figure was 64% for cases of non-neurodegenerative Parkinsonism. For all DaT scans, the diagnosis was changed in 37% of patients (n = 168), whilst the clinical management was changed in 42% of patients (n = 190). Change in management involved 63% starting dopaminergic medication, 5% stopping dopaminergic medications, and 31% undergoing other changes in management. Conclusion: DaT imaging is useful for confirming the correct diagnosis and clinical management for patients with clinically indeterminate Parkinsonism. Pre-scan diagnoses were generally consistent with scan results.Keywords
All Related Versions
This publication has 24 references indexed in Scilit:
- [¹²³I]FP‐CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug‐induced parkinsonisms: a meta‐analysisEuropean Journal of Neurology, 2014
- The relationship between cerebral vascular disease and parkinsonism: The VADO studyParkinsonism & Related Disorders, 2012
- Changes in Clinical Management and Diagnosis following DaTscan™ SPECT Imaging in Patients with Clinically Uncertain Parkinsonian Syndromes: A 12-Week Follow-Up StudyNeurodegenerative Diseases, 2012
- Drug-Induced ParkinsonismJournal of Clinical Neurology, 2012
- The prevalence of Parkinson’s disease in a rural area of North-East EnglandParkinsonism & Related Disorders, 2010
- Levodopa for the Treatment of Parkinson's DiseaseNew England Journal of Medicine, 2008
- The Prevalence of Parkinson’s Disease in an Area of North Tyneside in the North-East of EnglandNeuroepidemiology, 2006
- Impact of dopamine transporter SPECT using 123I‐Ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromesMovement Disorders, 2004
- Are men at greater risk for Parkinson's disease than women?Journal of Neurology, Neurosurgery & Psychiatry, 2004
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992